Loading…
Molecular hydrogen is comparable to sulfasalazine as a treatment for DSS-induced colitis in mice
Colitis is an inflammatory condition of the bowels associated with abdominal pain, diarrhea, fatigue, and fever. Its etiology is multifactorial but related to the overproduction of inflammatory and oxidative mediators. There is currently no cure for this disease, and drugs used to manage it often ha...
Saved in:
Published in: | EXCLI journal 2021-01, Vol.20, p.1106-1117 |
---|---|
Main Authors: | , , , , , |
Format: | Article |
Language: | English |
Subjects: | |
Online Access: | Get full text |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
cited_by | |
---|---|
cites | |
container_end_page | 1117 |
container_issue | |
container_start_page | 1106 |
container_title | EXCLI journal |
container_volume | 20 |
creator | LeBaron, Tyler W Asgharzadeh, Fereshteh Khazei, Majid Kura, Branislav Tarnava, Alex Slezak, Jan |
description | Colitis is an inflammatory condition of the bowels associated with abdominal pain, diarrhea, fatigue, and fever. Its etiology is multifactorial but related to the overproduction of inflammatory and oxidative mediators. There is currently no cure for this disease, and drugs used to manage it often have deleterious side effects. H
2
is recognized as having anti-inflammatory and antioxidant effects, which may qualify it as a novel therapeutic for colitis. We induced an acute model of colitis in mice by administering dextran sulfate sodium (DSS) in drinking water for seven days. Mice were divided into five groups (n=6); normal, colitis, H
2
-treated colitis, sulfasalazine-treated colitis, and H
2
plus sulfasalazine-treated colitis. From days three to ten, mice were given H
2
, sulfasalazine, or both. H
2
was administered via dissolving a hydrogen-generating tablet in water to make hydrogen-rich water (HRW), which was ingested ad libitum and via oral gavage (200 μL). The Disease Activity Index (DAI), histological changes, and markers of inflammation and oxidative stress were assessed. HRW and sulfasalazine significantly improved bodyweight, DAI, mucosal damage, crypt loss, and spleen weight compared to control. Both treatments significantly decreased inflammation (high-sensitive C-reactive protein) and restored redox balance (total thiol, superoxide dismutase, catalase activity). There was a trend for the combination treatment to be more effective than either HRW or sulfasalazine alone. Furthermore, HRW tended to be as effective as, and often more effective than, sulfasalazine. HRW may serve as a therapeutic for ameliorating DSS-induced colitis in mice. |
doi_str_mv | 10.17179/excli2021-3762 |
format | article |
fullrecord | <record><control><sourceid>proquest_pubme</sourceid><recordid>TN_cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_8326503</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>2558092949</sourcerecordid><originalsourceid>FETCH-LOGICAL-p243t-d14cd1857572c286002db2c04355133f2b7b22355081ecec7dbbdc37acfc92583</originalsourceid><addsrcrecordid>eNpVkL1PwzAUxC0EglKYWT2yBOznOE4WJFQ-pSKGwhwc-6UYOXGxE0T564kEA0x3T6f76ekIOeHsjCuuqnP8NN4BA54JVcAOmfGC8wy4LHb_-ANymNIbY7JkUu2TA5GLXIJgM_LyEDya0etIX7c2hjX21CVqQrfRUTce6RBoGn2rk_b6y_VIdaKaDhH10GE_0DZEerVaZa63o0E7Vb0bJoTraecMHpG9VvuEx786J88310-Lu2z5eHu_uFxmG8jFkFmeG8tLqaQCA2XBGNgGDMuFlFyIFhrVAEwHKzkaNMo2jTVCadOaCmQp5uTih7sZmw6tmV6L2teb6Dodt3XQrv6f9O61XoePuhRQSCYmwOkvIIb3EdNQdy4Z9F73GMZUg5zWq6DKK_ENyAByUg</addsrcrecordid><sourcetype>Open Access Repository</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>2558092949</pqid></control><display><type>article</type><title>Molecular hydrogen is comparable to sulfasalazine as a treatment for DSS-induced colitis in mice</title><source>PubMed Central (PMC)</source><creator>LeBaron, Tyler W ; Asgharzadeh, Fereshteh ; Khazei, Majid ; Kura, Branislav ; Tarnava, Alex ; Slezak, Jan</creator><creatorcontrib>LeBaron, Tyler W ; Asgharzadeh, Fereshteh ; Khazei, Majid ; Kura, Branislav ; Tarnava, Alex ; Slezak, Jan</creatorcontrib><description>Colitis is an inflammatory condition of the bowels associated with abdominal pain, diarrhea, fatigue, and fever. Its etiology is multifactorial but related to the overproduction of inflammatory and oxidative mediators. There is currently no cure for this disease, and drugs used to manage it often have deleterious side effects. H
2
is recognized as having anti-inflammatory and antioxidant effects, which may qualify it as a novel therapeutic for colitis. We induced an acute model of colitis in mice by administering dextran sulfate sodium (DSS) in drinking water for seven days. Mice were divided into five groups (n=6); normal, colitis, H
2
-treated colitis, sulfasalazine-treated colitis, and H
2
plus sulfasalazine-treated colitis. From days three to ten, mice were given H
2
, sulfasalazine, or both. H
2
was administered via dissolving a hydrogen-generating tablet in water to make hydrogen-rich water (HRW), which was ingested ad libitum and via oral gavage (200 μL). The Disease Activity Index (DAI), histological changes, and markers of inflammation and oxidative stress were assessed. HRW and sulfasalazine significantly improved bodyweight, DAI, mucosal damage, crypt loss, and spleen weight compared to control. Both treatments significantly decreased inflammation (high-sensitive C-reactive protein) and restored redox balance (total thiol, superoxide dismutase, catalase activity). There was a trend for the combination treatment to be more effective than either HRW or sulfasalazine alone. Furthermore, HRW tended to be as effective as, and often more effective than, sulfasalazine. HRW may serve as a therapeutic for ameliorating DSS-induced colitis in mice.</description><identifier>ISSN: 1611-2156</identifier><identifier>EISSN: 1611-2156</identifier><identifier>DOI: 10.17179/excli2021-3762</identifier><identifier>PMID: 34345230</identifier><language>eng</language><publisher>Leibniz Research Centre for Working Environment and Human Factors</publisher><subject>Original</subject><ispartof>EXCLI journal, 2021-01, Vol.20, p.1106-1117</ispartof><rights>Copyright © 2021 LeBaron et al. 2021</rights><lds50>peer_reviewed</lds50><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktopdf>$$Uhttps://www.ncbi.nlm.nih.gov/pmc/articles/PMC8326503/pdf/$$EPDF$$P50$$Gpubmedcentral$$Hfree_for_read</linktopdf><linktohtml>$$Uhttps://www.ncbi.nlm.nih.gov/pmc/articles/PMC8326503/$$EHTML$$P50$$Gpubmedcentral$$Hfree_for_read</linktohtml><link.rule.ids>230,314,727,780,784,885,27924,27925,53791,53793</link.rule.ids></links><search><creatorcontrib>LeBaron, Tyler W</creatorcontrib><creatorcontrib>Asgharzadeh, Fereshteh</creatorcontrib><creatorcontrib>Khazei, Majid</creatorcontrib><creatorcontrib>Kura, Branislav</creatorcontrib><creatorcontrib>Tarnava, Alex</creatorcontrib><creatorcontrib>Slezak, Jan</creatorcontrib><title>Molecular hydrogen is comparable to sulfasalazine as a treatment for DSS-induced colitis in mice</title><title>EXCLI journal</title><description>Colitis is an inflammatory condition of the bowels associated with abdominal pain, diarrhea, fatigue, and fever. Its etiology is multifactorial but related to the overproduction of inflammatory and oxidative mediators. There is currently no cure for this disease, and drugs used to manage it often have deleterious side effects. H
2
is recognized as having anti-inflammatory and antioxidant effects, which may qualify it as a novel therapeutic for colitis. We induced an acute model of colitis in mice by administering dextran sulfate sodium (DSS) in drinking water for seven days. Mice were divided into five groups (n=6); normal, colitis, H
2
-treated colitis, sulfasalazine-treated colitis, and H
2
plus sulfasalazine-treated colitis. From days three to ten, mice were given H
2
, sulfasalazine, or both. H
2
was administered via dissolving a hydrogen-generating tablet in water to make hydrogen-rich water (HRW), which was ingested ad libitum and via oral gavage (200 μL). The Disease Activity Index (DAI), histological changes, and markers of inflammation and oxidative stress were assessed. HRW and sulfasalazine significantly improved bodyweight, DAI, mucosal damage, crypt loss, and spleen weight compared to control. Both treatments significantly decreased inflammation (high-sensitive C-reactive protein) and restored redox balance (total thiol, superoxide dismutase, catalase activity). There was a trend for the combination treatment to be more effective than either HRW or sulfasalazine alone. Furthermore, HRW tended to be as effective as, and often more effective than, sulfasalazine. HRW may serve as a therapeutic for ameliorating DSS-induced colitis in mice.</description><subject>Original</subject><issn>1611-2156</issn><issn>1611-2156</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2021</creationdate><recordtype>article</recordtype><recordid>eNpVkL1PwzAUxC0EglKYWT2yBOznOE4WJFQ-pSKGwhwc-6UYOXGxE0T564kEA0x3T6f76ekIOeHsjCuuqnP8NN4BA54JVcAOmfGC8wy4LHb_-ANymNIbY7JkUu2TA5GLXIJgM_LyEDya0etIX7c2hjX21CVqQrfRUTce6RBoGn2rk_b6y_VIdaKaDhH10GE_0DZEerVaZa63o0E7Vb0bJoTraecMHpG9VvuEx786J88310-Lu2z5eHu_uFxmG8jFkFmeG8tLqaQCA2XBGNgGDMuFlFyIFhrVAEwHKzkaNMo2jTVCadOaCmQp5uTih7sZmw6tmV6L2teb6Dodt3XQrv6f9O61XoePuhRQSCYmwOkvIIb3EdNQdy4Z9F73GMZUg5zWq6DKK_ENyAByUg</recordid><startdate>20210101</startdate><enddate>20210101</enddate><creator>LeBaron, Tyler W</creator><creator>Asgharzadeh, Fereshteh</creator><creator>Khazei, Majid</creator><creator>Kura, Branislav</creator><creator>Tarnava, Alex</creator><creator>Slezak, Jan</creator><general>Leibniz Research Centre for Working Environment and Human Factors</general><scope>7X8</scope><scope>5PM</scope></search><sort><creationdate>20210101</creationdate><title>Molecular hydrogen is comparable to sulfasalazine as a treatment for DSS-induced colitis in mice</title><author>LeBaron, Tyler W ; Asgharzadeh, Fereshteh ; Khazei, Majid ; Kura, Branislav ; Tarnava, Alex ; Slezak, Jan</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-p243t-d14cd1857572c286002db2c04355133f2b7b22355081ecec7dbbdc37acfc92583</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2021</creationdate><topic>Original</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>LeBaron, Tyler W</creatorcontrib><creatorcontrib>Asgharzadeh, Fereshteh</creatorcontrib><creatorcontrib>Khazei, Majid</creatorcontrib><creatorcontrib>Kura, Branislav</creatorcontrib><creatorcontrib>Tarnava, Alex</creatorcontrib><creatorcontrib>Slezak, Jan</creatorcontrib><collection>MEDLINE - Academic</collection><collection>PubMed Central (Full Participant titles)</collection><jtitle>EXCLI journal</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>LeBaron, Tyler W</au><au>Asgharzadeh, Fereshteh</au><au>Khazei, Majid</au><au>Kura, Branislav</au><au>Tarnava, Alex</au><au>Slezak, Jan</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Molecular hydrogen is comparable to sulfasalazine as a treatment for DSS-induced colitis in mice</atitle><jtitle>EXCLI journal</jtitle><date>2021-01-01</date><risdate>2021</risdate><volume>20</volume><spage>1106</spage><epage>1117</epage><pages>1106-1117</pages><issn>1611-2156</issn><eissn>1611-2156</eissn><abstract>Colitis is an inflammatory condition of the bowels associated with abdominal pain, diarrhea, fatigue, and fever. Its etiology is multifactorial but related to the overproduction of inflammatory and oxidative mediators. There is currently no cure for this disease, and drugs used to manage it often have deleterious side effects. H
2
is recognized as having anti-inflammatory and antioxidant effects, which may qualify it as a novel therapeutic for colitis. We induced an acute model of colitis in mice by administering dextran sulfate sodium (DSS) in drinking water for seven days. Mice were divided into five groups (n=6); normal, colitis, H
2
-treated colitis, sulfasalazine-treated colitis, and H
2
plus sulfasalazine-treated colitis. From days three to ten, mice were given H
2
, sulfasalazine, or both. H
2
was administered via dissolving a hydrogen-generating tablet in water to make hydrogen-rich water (HRW), which was ingested ad libitum and via oral gavage (200 μL). The Disease Activity Index (DAI), histological changes, and markers of inflammation and oxidative stress were assessed. HRW and sulfasalazine significantly improved bodyweight, DAI, mucosal damage, crypt loss, and spleen weight compared to control. Both treatments significantly decreased inflammation (high-sensitive C-reactive protein) and restored redox balance (total thiol, superoxide dismutase, catalase activity). There was a trend for the combination treatment to be more effective than either HRW or sulfasalazine alone. Furthermore, HRW tended to be as effective as, and often more effective than, sulfasalazine. HRW may serve as a therapeutic for ameliorating DSS-induced colitis in mice.</abstract><pub>Leibniz Research Centre for Working Environment and Human Factors</pub><pmid>34345230</pmid><doi>10.17179/excli2021-3762</doi><tpages>12</tpages><oa>free_for_read</oa></addata></record> |
fulltext | fulltext |
identifier | ISSN: 1611-2156 |
ispartof | EXCLI journal, 2021-01, Vol.20, p.1106-1117 |
issn | 1611-2156 1611-2156 |
language | eng |
recordid | cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_8326503 |
source | PubMed Central (PMC) |
subjects | Original |
title | Molecular hydrogen is comparable to sulfasalazine as a treatment for DSS-induced colitis in mice |
url | http://sfxeu10.hosted.exlibrisgroup.com/loughborough?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2024-12-28T07%3A23%3A07IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_pubme&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Molecular%20hydrogen%20is%20comparable%20to%20sulfasalazine%20as%20a%20treatment%20for%20DSS-induced%20colitis%20in%20mice&rft.jtitle=EXCLI%20journal&rft.au=LeBaron,%20Tyler%20W&rft.date=2021-01-01&rft.volume=20&rft.spage=1106&rft.epage=1117&rft.pages=1106-1117&rft.issn=1611-2156&rft.eissn=1611-2156&rft_id=info:doi/10.17179/excli2021-3762&rft_dat=%3Cproquest_pubme%3E2558092949%3C/proquest_pubme%3E%3Cgrp_id%3Ecdi_FETCH-LOGICAL-p243t-d14cd1857572c286002db2c04355133f2b7b22355081ecec7dbbdc37acfc92583%3C/grp_id%3E%3Coa%3E%3C/oa%3E%3Curl%3E%3C/url%3E&rft_id=info:oai/&rft_pqid=2558092949&rft_id=info:pmid/34345230&rfr_iscdi=true |